Effect of high-dose methylprednisolone treatment on Th17 cells in patients with multiple sclerosis in relapse

被引：28

作者：

Liu, M. ^{[1
]}

Hu, X. ^{[1
]}

Wang, Y. ^{[1
]}

Peng, F. ^{[1
]}

Yang, Y. ^{[1
]}

Chen, X. ^{[1
]}

Lu, Z. ^{[1
]}

Zheng, X. ^{[1
]}

机构：

[1] Sun Yat Sen Univ, Dept Neurol, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China

来源：

ACTA NEUROLOGICA SCANDINAVICA | 2009年 / 120卷 / 04期

关键词：

glucocorticoids; IL-17; IL-23R; multiple sclerosis; RORc; Th17; cells; REGULATORY T-CELLS; SHORT-TERM; EXPRESSION; CORTICOSTEROIDS; INTERLEUKIN-17; BLOOD; GLUCOCORTICOIDS; DIFFERENTIATION; LYMPHOCYTES; DISTINCT;

D O I：

10.1111/j.1600-0404.2009.01158.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Objectives - Growing evidences have suggested that Th17 cells are involved in the pathogenic mechanisms of multiple sclerosis (MS). Treatment with high-dose intravenous methylprednisolone (IVMP) has beneficial effects on functional recovery in patients with MS during relapse. The present study was designed to analyze the influences of IVMP on Th17 cells in patients with MS after a 5-day high-dose IVMP treatment. Materials and methods - Th17 cell count and the production of IL-17 in peripheral blood mononuclear cells (PBMCs) were measured using flow cytometry and ELISA respectively. Quantitative real-time PCR was performed to analyze the mRNA expression of Th17 cell-related factors (IL-17, RORc and IL-23R) in PBMCs. Results - A significant reduction in IL-17 production and Th17 cells count in PBMCs was found in patients with MS after IVMP treatment. Moreover, the expression of IL-17, IL-23R and RORc mRNA decreased significantly after IVMP treatment. Conclusions - Treatment with methylprednisolone has a suppressive effect on Th17 cells and may be related to its clinical efficiency.

引用

页码：235 / 241

页数：7

共 36 条

[1] The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease [J].

Afzali, B. ;

Lombardi, G. ;

Lechler, R. I. ;

Lord, G. M. .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 148 (01) :32-46

[2] CD4+CD25+ regulatory T cells (TREG) in Systemic Lupus Erythematosus (SLE) patients:: The possible influence of treatment with corticosteroids [J].

Azab, N. A. ;

Bassyouni, I. H. ;

Emad, Y. ;

El-Wahab, G. A. Abd ;

Hamdy, G. ;

Mashahit, M. A. .

CLINICAL IMMUNOLOGY, 2008, 127 (02) :151-157

[3] TH-17 cells in the circle of immunity and autoimmunity [J].

Bettelli, Estelle ;

Oukka, Mohamed ;

Kuchroo, Vijay K. .

NATURE IMMUNOLOGY, 2007, 8 (04) :345-350

[4]

BRAITCH M, 2008, ACTA NEUROL SCA 0822

[5] Airway remodeling-associated mediators in moderate to severe asthma:: Effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression [J].

Chakir, J ;

Shannon, J ;

Molet, S ;

Fukakusa, M ;

Elias, J ;

Laviolette, M ;

Boulet, LP ;

Hamid, Q .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (06) :1293-1298

[6] Distinct regulation of interleukin-17 in human T helper lymphocytes [J].

Chen, Zhi ;

Tato, Cristina M. ;

Muul, Linda ;

Laurence, Arian ;

O'Shea, John J. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (09) :2936-2946

[7] Glucocorticoids and the Th1/Th2 balance [J].

Elenkov, IJ .

GLUCOCORTICOID ACTION: BASIC AND CLINICAL IMPLICATIONS, 2004, 1024 :138-146

[8] Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [J].

Harrington, LE ;

Hatton, RD ;

Mangan, PR ;

Turner, H ;

Murphy, TL ;

Murphy, KM ;

Weaver, CT .

NATURE IMMUNOLOGY, 2005, 6 (11) :1123-1132

[9] Evidence for cytokine dysregulation in multiple sclerosis: Peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission [J].

Hollifield, RD ;

Harbige, LS ;

Pham-Dinh, D ;

Sharief, MK .

AUTOIMMUNITY, 2003, 36 (03) :133-141

[10] Transcriptional regulation of Th17 cell differentiation [J].

Ivanov, Ivaylo I. ;

Zhou, Liang ;

Littman, Dan R. .

SEMINARS IN IMMUNOLOGY, 2007, 19 (06) :409-417

← 1 2 3 4 →